BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing